Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-17

Clinical Trial Update: Vedolizumab for the Treatment of Collagenous Gastritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating vedolizumab for collagenous gastritis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entyvio (vedolizumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Collagenous Gastritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING